One approach used short-hairpin RNA (shRNA) interference targeting IL-1R1 in the paraventricular nucleus (PVN), leading to reduced local IL-1R1 expression and downregulated sympathetic activity and improved myocardial remodeling, two important mechanisms underlying hypertension [252]. The gene discussed is IL1R1; the disease is Hypertension.